Danish drugmaker Genmab and its U.S. partner AbbVie said on Friday that their drug for a type of blood cancer failed to ...

'Sell America': Investors dump US assets in fear of the end of Fed independence Trump calls for 10% cap on credit card ...

UnitedHealth used aggressive tactics to boost Medicare payments, Senate report finds ...

Genmab (GMAB) on Friday announced that its bispecific antibody epcoritamab, marketed as Epkinly in partnership with AbbVie ...

By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...

Kate Middleton, the Princess of Wales, opened up about her experience with chemotherapy during a visit to a London hospital. ...

Accrual in this trial was suspended in March 2025 as a result of findings from the Checkmate 8HW trial, which showed that the ...

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...

Two prominent members of San Diego’s news media admit they are changed people entering 2026 after their journey with cancer ...

"Agenus and Zydus complete $141m BOT+BAL immunotherapy collaboration deal" was originally created and published by ...

The company said that responding patients lived longer overall, with a median survival of 16.2 months. ・The data come from ...